No Clear Winner Between Lidocaine and Amiodarone for In-Hospital Refractory VF/pVT: A Chinese Registry Analysis

Xu Niu, Tangxing Jiang, Wen Zheng, et al.

Summary: This study compared two medications — lidocaine and amiodarone — used during a specific type of life-threatening cardiac arrest (where the heart's electrical rhythm is dangerously abnormal and does not respond to electric shocks). Researchers drew on registry data from 40 hospitals across China, identifying 612 patients out of more than 32,000 cardiac arrest cases who met the study criteria. They found no statistically significant difference between the two drugs in survival to hospital discharge, return of a stable heartbeat, or favorable brain function outcomes.

Why it matters: Medical guidelines currently allow doctors to choose either drug in this situation, largely based on studies of cardiac arrests that happened outside a hospital. Cardiac arrests inside hospitals are different in important ways — patients are already being monitored, medical staff respond faster, and the underlying causes differ. This study provides real-world evidence specifically for in-hospital cardiac arrest, offering some reassurance that the guideline's flexibility on drug choice is not obviously wrong in this setting.

What to keep in mind: The most important limitation is that only 612 patients out of more than 32,000 qualified for this analysis — a small group for this kind of comparison. The results are consistent with either drug being better, worse, or truly equivalent; the study simply was not large enough to detect a meaningful difference if one exists. Because patients were not randomly assigned to a drug, the choice of medication may have been influenced by factors the researchers could not measure, such as how the patient appeared to be doing at the time of the arrest or which drugs were available at that hospital. The study was also conducted partly during the COVID-19 pandemic, which may have affected how cardiac arrests were managed. The findings apply most directly to Chinese hospital settings, where lidocaine has historically been used more often than in Western countries.

Relevance: Registry and Real-World Data Methods

Source: https://pubmed.ncbi.nlm.nih.gov/42767592/

---